MA et al. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male. 2003 Mar;6(1):1-7.
Burris A et al. A long-term, prospective study of the physiologic and behavioral effects of hormone replacement in untreated hypogonadal men. J Androl 1992 Jul-Aug;13(4):297-304
Caminiti G et al. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol. 2009 Sep 1;54(10):919-27
Caretta N et al. Erectile dysfunction in aging men: testosterone role in therapeutic protocols. J Endocrinol Invest. 2005; 28 (11 Suppl Proceedings):108-11
Cassidenti D et al. Effects of sex steroids on skin 5 alpha-reductase activity in vitro Obstetrics & Gynecology 1991; 78:103-107
Channer KS, Jones TH Cardiovascular effects of testosterone: implications of the "male menopause"? Heart. 2003 Feb; 89(2):121-2.
Chen C et al. Cancer Epidemiol Biomarkers Prev. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial. 2003 Dec; 12(12):1410-6.
Cooper CS et al. Effect of exogenous testosterone on prostate volume, serum and semen prostate specific antigen levels in healthy young men J Urol 1998 Feb; 159(2):441-3
Daniell HW et al. Hypogonadism in men consuming sustained-action oral opioids. J Pain. 2002 Oct; 3(5):377-84.
Dimitrakakis C et al. Breast cancer incidence in women using testosterone in addition to usual hormone therapy. Menopause 11 (5) 2004
Edinger KL et al. Testosterone's anti-anxiety and analgesic effects may be due in part to actions of its 5alpha-reduced metabolites in the hippocampus. Psychoneuroendocrinology. 2005 Jun; 30(5):418-30
El-Sakka AI et al. Prostatic specific antigen in patients with hypogonadism: effect of testosterone replacement. J Sex Med. 2005 Mar; 2(2):235-40,
Endogenous Sex Hormones and Prostate Cancer: A Collaborative Analysis of 18 Prospective Studies Endogenous Hormones and Prostate Cancer Collaborative Group. J Natl Cancer Inst 2008 100: 170-183
English KM et al. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study. Circulation 2000 Oct 17; 102(16):1906-11
Fink B et al. The 2nd-4th digit ratio (2D:4D) and neck circumference: implications for risk factors in coronary heart disease. Int J Obes (Lond). 2006 Apr; 30(4):711-4
Foresta C et al. Reduced Number of Circulating Endothelial Progenitor Cells in Hypogonadal Men. Journal of Clinical Endocrinology & Metabolism 91(11):4599–4602
Fukui, M et al. Diabetes Care 26:1869–1873, June, 2003
Gould DC, Kirby RS Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?Prostate Cancer Prostatic Dis. 2006;9(1):14-8
Gouras GK et al. Proc Natl Acad Sci U S A 2000 Feb 1; 97(3):1202-5
Gray A, Feldman HA, McKinlay JB, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 1991;73:1016-1025.
Gunawardena, K et al. Testosterone is a potential augmentor of antioxidant induced apoptosis in human prostate cancer cells. Cancer Detect Prev. 2002; 26(2):105-13
Habib FK, et al. Serenoa repens (Permixon) inhibits the 5alpha-reductase activity of human prostate cancer cell lines without interfering with PSA expression. Int J Cancer. 2005 Mar 20; 114(2):190-4.
Hak, Elisabeth et al. Low Levels of Endogenous Androgens Increase the Risk of Atherosclerosis in Elderly Men: The Rotterdam Study. The Journal of Clinical Endocrinology & Metabolism Vol. 87, 2002, No. 8 3632-3639
Hatzoglou A. et al. Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo. (Journal of Clinical Endocrinology & Metabolism 2004, 10.1210/jc.2004-0801)
Hau M et al. Testosterone reduces responsiveness to nociceptive stimuli in a wild bird. Horm Behav. 2004 Aug; 46(2):165-70.
Hoffman MA. Is low serum free testosterone a marker for high grade prostate cancer? J Urol 2000 Mar; 163(3):824-7
Hogervorst E et al. Low free testosterone is an independent risk factor for Alzheimer's disease. Exp Gerontol. 2004 Nov-Dec; 39(11-12):1633-9.
Holland J, Bandelow S, Hogervorst E. Testosterone levels and cognition in elderly men: a review. Maturitas. 2011;69:322-337.
Iczkowski, K. et al. The Dual 5 alpha reductase inhibitor dutasteride induces atrophic changes and decreases cancer volume in the human prostate. Urology 65:76-82, 2005
Jankowska EA. Circulating estradiol and mortality in men with systolic chronic heart failure. JAMA. 2009 May 13; 301(18):1892-901.
Janowsky JS. Thinking with your gonads: testosterone and cognition. Trends Cogn Sci. 2006 Feb;10(2):77-82.
Jeong, HJ et al. Inhibition of aromatase activity by flavinoids. ArchPharm Res. 1999 Jun; 22(3):309-12
Jones TH, Arver S, Behre HM, et al; TIMES2 Investigators. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care. 2011;34:828-837.
Daniel M Kelly and T Hugh Jones. “Testosterone: a vascular hormone in health and disease,” J Endocrology 217:3 R47–R71.
Keogh E Can a sexually dimorphic index of prenatal hormonal exposure be used to examine cold pressor pain perception in men and women? : Eur J Pain. 2006 Apr 4
Khaw KT, Barrett-Connor EJ. Blood pressure and endogenous testosterone in men: an inverse relationship. Hypertens. 1988 Apr; 6(4):329-32.
Khaw KT. et al. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men. Circulation. 2007; 116:2694-2701
Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM. Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS). J Sex Med. 2011;8:3204-3213.
Korbonits M, Slawik M A comparison of a novel testosterone bioadhesive buccal system, striant, with a testosterone adhesive patch in hypogonadal males J Clin Endocrinol Metab. 2004 May; 89(5):2039-43
Korenman SG, Morley JE, Mooradian AD, et al. 1990 Secondary hypogonadism in older men: its relationship to impotence. J Clin Endocrinol Metab. 71:963–969.
Ekaterina L. Kovacheva, Amiya P. Sinha Hikim, Ruoqing Shen, Indranil Sinha, Indrani Sinha-Hikim. “ Testosterone Supplementation Reverses Sarcopenia
in Aging through Regulation of Myostatin, c-Jun NH2-Terminal Kinase, Notch, and Akt Signaling Pathways.” Endocrinology, Feb. 2010; 151(2):628–638.
Kupelian V et al. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are
